Alveolar soft-part sarcoma. A clinico-pathologic study of half a century
Population
102 patients with alveolar soft-part sarcoma examined between 1923 and 1986
Design
Cohort
Follow-up
Median 7 years (range 1 month to 27 years)
Authors
Discussion
Loading...
Member takes
Implication
May support aggressive surgery for extended survival in non-metastatic alveolar soft-part sarcoma; challenges muscle tumor consensus.
Structured PICO
P
Population
102 patients with alveolar soft-part sarcoma (ASPS) examined between 1923 and 1986 (follow-up available for 91)
I
Intervention
Aggressive surgical excision (some received chemo and/or radiotherapy)
O
Outcome
Survival and local recurrencehard clinical
In patients with alveolar soft-part sarcoma, aggressive surgical excision is the primary therapeutic option, and survival can be prolonged even with metastases.
Limitations
- Small numbers for chemo/radiotherapy comparison
- Staging not uniform
Cite This Study
Lieberman et al. (1989) studied this question.